Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T02:28:05.791Z Has data issue: false hasContentIssue false
  • English
  • Français

The tolerability and efficacy of ziprasidone in the treatment of children and adolescents with tourette's syndrome (TS)

Published online by Cambridge University Press:  16 April 2020

P. Chappell  and
F. Sallee
P. Chappell
Affiliation:
Central Research Division, Pfizer Inc,Groton, CT 06340
F. Sallee
Affiliation:
lnstitute of Psychiatry, Charleston, SCSC 29425, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 313s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.